AB
GLSI icon

Amalgamated Bank’s Greenwich LifeSciences GLSI Stock Holding History

Amalgamated Bank’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-197
Closed -$4K – 2117
2025
Q4 		$4K Sell
197
-10
-5% -$105 ﹤0.01% 2784
2025
Q3 		$2K Hold
207
– – ﹤0.01% 2929
2025
Q2 		$2K Hold
207
– – ﹤0.01% 2961
2025
Q1 		$2K Hold
207
– – ﹤0.01% 2840
2024
Q4 		$2K Hold
207
– – ﹤0.01% 2900
2024
Q3 		$3K Hold
207
– – ﹤0.01% 2875
2024
Q2 		$4K Buy
+207
New +$3.02K ﹤0.01% 2849
2022
Q2 		– Sell
-667
Closed -$13K – 3098
2022
Q1 		$13K Buy
+667
New +$13.5K ﹤0.01% 2911

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Amalgamated Bank's GLSI Position: Q1 2026 in Review

Amalgamated Bank sold out of Greenwich LifeSciences (GLSI) in Q1 2026, closing a stake of 197 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in GLSI in Q1 2022 and held it in 8 quarters. The position peaked at $13K in Q1 2022. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Amalgamated Bank reported no remaining Greenwich LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 197 Greenwich LifeSciences shares in Q1 2026, an estimated $4K.
  • Amalgamated Bank first reported a position in Greenwich LifeSciences in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Greenwich LifeSciences position peaked at $13K in Q1 2022.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.